Narusheniya menstrual'nogo tsikla u podrostkovi molodykh zhenshchin s ozhireniem
Obesity plays a key role in reproductive disorders. Xenical administration results in recovery of menstrual function in 78.9% and ovulation in 26.3% of patients with obesity. Hormone therapy in patients with obesity should be accompanied with Xenical therapy, which has a favorable impact on further...
Format: | Article |
---|---|
Language: | English |
Published: |
Endocrinology Research Centre
2010-12-01
|
Series: | Ожирение и метаболизм |
Subjects: | |
Online Access: | https://www.omet-endojournals.ru/jour/article/view/5085 |
_version_ | 1827121769299836928 |
---|---|
collection | DOAJ |
description | Obesity plays a key role in reproductive disorders. Xenical administration results in recovery of menstrual function in 78.9% and ovulation in 26.3% of patients with obesity. Hormone therapy in patients with obesity should be accompanied with Xenical therapy, which has a favorable impact on further body weight reduction (13.95% from baseline) and improvement (or stability) of metabolic parameters. |
first_indexed | 2024-03-08T09:14:11Z |
format | Article |
id | doaj.art-5c442b7f0753433690868380a3b5f0d9 |
institution | Directory Open Access Journal |
issn | 2071-8713 2306-5524 |
language | English |
last_indexed | 2025-03-20T13:58:24Z |
publishDate | 2010-12-01 |
publisher | Endocrinology Research Centre |
record_format | Article |
series | Ожирение и метаболизм |
spelling | doaj.art-5c442b7f0753433690868380a3b5f0d92024-09-11T16:17:47ZengEndocrinology Research CentreОжирение и метаболизм2071-87132306-55242010-12-0174293410.14341/2071-8713-50855043Narusheniya menstrual'nogo tsikla u podrostkovi molodykh zhenshchin s ozhireniemObesity plays a key role in reproductive disorders. Xenical administration results in recovery of menstrual function in 78.9% and ovulation in 26.3% of patients with obesity. Hormone therapy in patients with obesity should be accompanied with Xenical therapy, which has a favorable impact on further body weight reduction (13.95% from baseline) and improvement (or stability) of metabolic parameters.https://www.omet-endojournals.ru/jour/article/view/5085obesitymenstrual dysfunctionadolescentsorlistatxenical |
spellingShingle | Narusheniya menstrual'nogo tsikla u podrostkovi molodykh zhenshchin s ozhireniem Ожирение и метаболизм obesity menstrual dysfunction adolescents orlistat xenical |
title | Narusheniya menstrual'nogo tsikla u podrostkovi molodykh zhenshchin s ozhireniem |
title_full | Narusheniya menstrual'nogo tsikla u podrostkovi molodykh zhenshchin s ozhireniem |
title_fullStr | Narusheniya menstrual'nogo tsikla u podrostkovi molodykh zhenshchin s ozhireniem |
title_full_unstemmed | Narusheniya menstrual'nogo tsikla u podrostkovi molodykh zhenshchin s ozhireniem |
title_short | Narusheniya menstrual'nogo tsikla u podrostkovi molodykh zhenshchin s ozhireniem |
title_sort | narusheniya menstrual nogo tsikla u podrostkovi molodykh zhenshchin s ozhireniem |
topic | obesity menstrual dysfunction adolescents orlistat xenical |
url | https://www.omet-endojournals.ru/jour/article/view/5085 |